Hugh Welles

Hugh Welles

Vaccitech Limited - Rome / United States
Others
AD Scientific Index ID: 4396756
person_outline Hugh Welles's MOST POPULAR ARTICLES
1-) Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human …KC Conlon, E Lugli, HC Welles, SA Rosenberg, AT Fojo, JC Morris, ...Journal of clinical oncology 33 (1), 74-82, 20157032015
2-) Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIVM Roederer, BF Keele, SD Schmidt, RD Mason, HC Welles, W Fischer, ...Nature 505 (7484), 502-508, 20141532014
3-) Immune-complexed adenovirus induce AIM2-mediated pyroptosis in human dendritic cellsK Eichholz, T Bru, TTP Tran, P Fernandes, H Welles, FJD Mennechet, ...PLoS pathogens 12 (9), e1005871, 2016752016
4-) Lack of Mycobacterium tuberculosis–specific interleukin‐17A–producing CD4+ T cells in active diseaseM Perreau, V Rozot, HC Welles, F Belluti‐Enders, S Vigano, M Maillard, ...European journal of immunology 43 (4), 939-948, 2013782013
5-) Targeted isolation of antibodies directed against major sites of SIV Env vulnerabilityRD Mason, HC Welles, C Adams, BK Chakrabarti, J Gorman, T Zhou, ...PLoS Pathogens 12 (4), e1005537, 2016732016